Quarterly report · Q3
3154.TEDINET S100QPVK
Period2022-07-01 → 2023-03-31
Filed2023-05-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Amended by S100RJV8 (2023-08-14).
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥177.5bn | 2022-07-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥221.7bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥169.9bn | 2021-07-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥2.4bn | 2022-07-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥3.3bn | 2021-07-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥2.8bn | 2022-07-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.8bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.7bn | 2021-07-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.9bn | 2022-07-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.6bn | 2021-07-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.8bn | 2022-07-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.9bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.5bn | 2021-07-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.8bn | 2022-07-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥2.5bn | 2021-07-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥105.8bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥93.0bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥100.5bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥87.4bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥75.6bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥18.4bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥17.3bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥17.7bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥11.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.1bn | at 2022-06-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥81.92 | 2022-07-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.72 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.3 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.21 | 2021-07-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.81 | 2022-01-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥81.67 | 2022-07-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥85.15 | 2021-07-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥116.11 | 2021-07-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 17.4% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.6% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2023-03-31 | −¥176,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2023-03-31 | −¥176,000 |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2023-03-31 | −¥5.5bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥173.4bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥173.4bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥176,000 |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥7.5bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥4.1bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥4.1bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥315m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2023-03-31 | ¥177.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2023-03-31 | ¥177.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥176,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2023-03-31 | ¥7.9bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2022-03-31 | −¥5.0bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥165.9bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥165.9bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥7.9bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥4.1bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥4.1bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥406m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2022-03-31 | ¥169.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2022-03-31 | ¥169.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2022-03-31 | ¥8.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 378
| Item | Context | Value | Unit |
|---|---|---|---|
| Interest expenses noe | Prior1YTDDuration | 50129000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 64758000 | JPY |
| Equity in losses of affiliates noe | Prior1YTDDuration | - | JPY |
| Equity in losses of affiliates noe | CurrentYTDDuration | 48000 | JPY |
| Other noe | Prior1YTDDuration | 8366000 | JPY |
| Other noe | CurrentYTDDuration | 10588000 | JPY |
| Non operating expenses | Prior1YTDDuration | 58495000 | JPY |
| Non operating expenses | CurrentYTDDuration | 75394000 | JPY |
| Ordinary income | Prior1YTDDuration | 3675498000 | JPY |
| Ordinary income | CurrentYTDDuration | 2777299000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 4177000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 6455000 | JPY |
| Gain on sales of investment securities ei | Prior1YTDDuration | - | JPY |
| Gain on sales of investment securities ei | CurrentYTDDuration | 108328000 | JPY |
| Extraordinary income | Prior1YTDDuration | 4177000 | JPY |
| Extraordinary income | CurrentYTDDuration | 114784000 | JPY |
| Loss on sales of noncurrent assets el | Prior1YTDDuration | - | JPY |
| Loss on sales of noncurrent assets el | CurrentYTDDuration | 1840000 | JPY |
| Loss on retirement of noncurrent assets el | Prior1YTDDuration | 3550000 | JPY |
| Loss on retirement of noncurrent assets el | CurrentYTDDuration | 2718000 | JPY |
| Impairment loss el | Prior1YTDDuration | 39145000 | JPY |
| Impairment loss el | CurrentYTDDuration | 9916000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 42695000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 14475000 | JPY |
| Income before income taxes | Prior1YTDDuration | 3636979000 | JPY |
| Income before income taxes | CurrentYTDDuration | 2877608000 | JPY |
| Income taxes current | Prior1YTDDuration | 1345392000 | JPY |
| Income taxes current | CurrentYTDDuration | 986806000 | JPY |
| Income taxes deferred | Prior1YTDDuration | -252329000 | JPY |
| Income taxes deferred | CurrentYTDDuration | 94704000 | JPY |
| Income taxes | Prior1YTDDuration | 1093063000 | JPY |
| Income taxes | CurrentYTDDuration | 1081510000 | JPY |
| Profit loss | Prior1YTDDuration | 2543915000 | JPY |
| Profit loss | CurrentYTDDuration | 1796097000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 2543915000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 1796097000 | JPY |
| Profit loss | Prior1YTDDuration | 2543915000 | JPY |
| Profit loss | CurrentYTDDuration | 1796097000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -319168000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | -297354000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | 12586000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | 11718000 | JPY |
| Other comprehensive income | Prior1YTDDuration | -306581000 | JPY |
| Other comprehensive income | CurrentYTDDuration | -285636000 | JPY |
| Comprehensive income | Prior1YTDDuration | 2237334000 | JPY |
| Comprehensive income | CurrentYTDDuration | 1510461000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 2237334000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 1510461000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E22995-000MedicalEquipmentSalesReportableSegmentsMember | 165868583000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E22995-000NursingCareAndWelfareReportableSegmentsMember | 4064977000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |